Peroxisome proliferator-activated receptor γ agonists inhibit adipocyte expression of α1-acid glycoprotein

Cell Biology International

Volumn 31, Issue 6, 2007, Pages 586-591

  Castriota, Gino ^a   Thompson, G Marie ^a   Lin, Ying ^b   Scherer, Philipp E ^b,c   Moller, David E ^a   Berger, Joel P ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c Training Center   (United States)

Author keywords

1 acid glycoprotein; Adipocyte; Peroxisome proliferator activated receptor

Indexed keywords

2 [2 (4 PHENOXY 2 PROPYLPHENOXY)ETHYL]INDOL 5 ACETIC ACID; 2,4 THIAZOLIDINEDIONE DERIVATIVE; 5 [4 [2 (5 METHYL 2 PHENYL 4 OXAZOLY) 2 HYDROXYETHOXY]BENZYL] 2,4 THIAZOLIDINEDIONE; ALPHA 1 ADRENERGIC RECEPTOR; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PLASMINOGEN ACTIVATOR INHIBITOR 1; ROSIGLITAZONE; TZD 2; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; DOWN REGULATION; EMBRYO; GENE CONTROL; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS INHIBITION; PROTEIN SYNTHESIS REGULATION;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; CELL DIFFERENTIATION; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; MICE; OROSOMUCOID; PPAR GAMMA; RNA, MESSENGER; THIAZOLIDINEDIONES; TIME FACTORS;

EID: 34247579180     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellbi.2006.11.033     Document Type: Article

References (26)

1. Bays H., Mandarino L., and DeFronzo R.A. Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach. J Clin Endocrinol Metab 89 (2004) 463-478
2. Berger J., Tanen M., Elbrecht A., Hermanowski-Vosatka A., Moller D.E., Wright S.D., et al. Peroxisome proliferator-activated receptor-gamma ligands inhibit adipocyte 11beta-hydroxysteroid dehydrogenase type 1 expression and activity. J Biol Chem 276 (2001) 12629-12635
3. Berger J.P., Akiyama T.E., and Meinke P.T. PPARs: therapeutic targets for metabolic disease. Trends Pharmacol Sci 26 (2005) 244-251
4. Boncela J., Papiewska I., Fijalkowska I., Walkowiak B., and Cierniewski C.S. Acute phase protein alpha 1-acid glycoprotein interacts with plasminogen activator inhibitor type 1 and stabilizes its inhibitory activity. J Biol Chem 276 (2001) 35305-35311
5. Boutten A., Dehoux M., Deschenes M., Rouzeau J.D., Bories P.N., and Durand G. Alpha 1-acid glycoprotein potentiates lipopolysaccharide-induced secretion of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha by human monocytes and alveolar and peritoneal macrophages. Eur J Immunol 22 (1992) 2687-2695
6. Ebeling P., Teppo A.M., Koistinen H.A., Viikari J., Ronnemaa T., Nissen M., et al. Troglitazone reduces hyperglycaemia and selectively acute-phase serum proteins in patients with Type II diabetes. Diabetologia 42 (1999) 1433-1438
7. Fournier T., Bouach N., Delafosse C., Crestani B., and Aubier M. Inducible expression and regulation of the alpha 1-acid glycoprotein gene by alveolar macrophages: prostaglandin E2 and cyclic AMP act as new positive stimuli. J Immunol 163 (1999) 2883-2890
8. Fournier T., Medjoubi N.N., and Porquet D. Alpha-1-acid glycoprotein. Biochim Biophys Acta 1482 (2000) 157-171
9. Hollenberg A.N., Susulic V.S., Madura J.P., Zhang B., Moller D.E., Tontonoz P., et al. Functional antagonism between CCAAT/Enhancer binding protein-alpha and peroxisome proliferator-activated receptor-gamma on the leptin promoter. J Biol Chem 272 (1997) 5283-5290
10. Kallen C.B., and Lazar M.A. Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes. Proc Natl Acad Sci USA 93 (1996) 5793-5796
11. Lehmann J.M., Moore L.B., Smith-Oliver T.A., Wilkison W.O., Willson T.M., and Kliewer S.A. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ. J Biol Chem 270 (1995) 12953-12956
12. Libby P., and Theroux P. Pathophysiology of coronary artery disease. Circulation 111 (2005) 3481-3488
13. Miles P.D.G., Romeo O.M., Higo K., Cohen A., Rafaat K., and Olefsky J.M. TNF-alpha induced insulin resistance in vivo and its prevention by troglitazone. Diabetes 46 (1997) 1678-1683
14. Moller D.E., and Berger J.P. Role of PPARs in the regulation of obesity-related insulin sensitivity and inflammation. Int J Obes Relat Metab Disord 27 Suppl. 3 (2003) S17-S21
15. Nakamura T., Board P.G., Matsushita K., Tanaka H., Matsuyama T., and Matsuda T. Alpha 1-acid glycoprotein expression in human leukocytes: possible correlation between alpha 1-acid glycoprotein and inflammatory cytokines in rheumatoid arthritis. Inflammation 17 (1993) 33-45
16. Peraldi P., Xu M., and Spiegelman B.M. Thiazolidinediones block tumor necrosis factor-alpha-induced inhibition of insulin signaling. J Clin Invest 100 (1997) 1863-1869
17. Shibata Y., Tamura K., and Ishida N. Cultured human monocytes, granulocytes and a monoblastoid cell line (THP-1) synthesize and secrete immunosuppressive acidic protein (a type of alpha 1-acid glycoprotein). Microbiol Immunol 28 (1984) 99-111
18. Staels B., and Fruchart J.C. Therapeutic roles of peroxisome proliferator-activated receptor agonists. Diabetes 54 (2005) 2460-2470
19. Su S.J., and Yeh T.M. Effects of alpha 1-acid glycoprotein on tissue factor expression and tumor necrosis factor secretion in human monocytes. Immunopharmacology 34 (1996) 139-145
20. Sugawara A., Takeuchi K., Uruno A., Ikeda Y., Arima S., Kudo M., et al. Transcriptional suppression of type 1 angiotensin II receptor gene expression by peroxisome proliferator-activated receptor-gamma in vascular smooth muscle cells. Endocrinology 142 (2001) 3125-3134
21. Szalkowski D., White-Carrington S., Berger J., and Zhang B. Antidiabetic thiazolidinediones block the inhibitory effect of tumor necrosis factor-α on differentiation, insulin-stimulated glucose uptake, and gene expression in 3T3-L1 cells. Endocrinology 136 (1995) 1474-1481
22. Tilg H., Vannier E., Vachino G., Dinarello C.A., and Mier J.W. Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells. J Exp Med 178 (1993) 1629-1636
23. Tontonoz P., Hu E., Devine J., Geale E.G., and Spiegelman B.M. PPARγ2 regulates adipose expression of the phospoenolpyruvate carboxykinase gene. Mol Cell Biol 15 (1995) 351-357
24. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., and Ferrante Jr. A.W. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112 (2003) 1796-1808
25. Wellen K.E., and Hotamisligil G.S. Inflammation, stress, and diabetes. J Clin Invest 115 (2005) 1111-1119
26. Xu H., Barnes G.T., Yang Q., Tan G., Yang D., Chou C.J., et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112 (2003) 1821-1830